Bite 1: Current scenario in HER2 and HER3 positive disease
Finish all modules to obtain your certification
Module 12 videos
2 videos
Unmet medical needs in HER2+ breast cancer
Eva Ciruelos: Hospital Universitario 12 de Octubre de Madrid
Maria Vidal: Hospital Clínic de Barcelona
Module 22 videos
2 videos
Measuring HER2 and HER3 expression in breast cancer
Aleix Prat: Hospital Clínic de Barcelona/IDIBAPS
Laia Bernet: Hospitales del Grupo Ribera Salud (Alzira, València)
Module 32 videos
2 videos
Mechanisms of resistance to anti-HER2 therapy in HER2+ disease
Joan Albanell: Hospital del Mar de Barcelona/IMIM
Sònia Pernas: Institut Català d’Oncologia (H. de Llobregat, Barcelona)
Module 42 videos
2 videos
Future therapies for HER2-expressing and HER3-expressing breast cancer
Cristina Saura: H. Universitari de la Vall d’Hebron/VHIO (Barcelona)
Santiago Escrivá de Romaní: H. Universitari de la Vall d’Hebron/VHIO (Barcelona)
Module 52 videos
2 videos
HER2low: new population and emerging drugs
Mireia Margelí: Institut Català d’Oncologia (Badalona, Barcelona)
Juan Miguel Cejalvo: Hospital Clínico Uniersitario de Valencia/INCLIVA
If you have doubts about any of the aspects of the syllabus, you can send us an email to events@gruposolti.org and we will respond as soon as possible.
